Literature DB >> 10716073

Clostridial bacteremia in the community hospital.

R I Haddy1, D D Nadkarni, B L Mann, D R Little, T D Domers, R D Clover, M J Silvers.   

Abstract

Anaerobic infections are not commonly studied in the community hospital. The aim of this study was to determine demographic factors, the portals of entry and underlying disorders for clostridial bacteremia and to determine whether appropriate (recommended) treatment is effective. Medical records were reviewed for 42 patients with clostridial bacteremia at 1 Florida, USA, hospital and 4 Dayton, Ohio, USA, hospitals. Fourteen (33.3%) of the patients had clostridial micro-organisms that were isolated in cultures with polymicrobial isolates. Only about half of the patients had fever at the onset of their bacteremia and only slightly more than half had elevated leukocyte counts. The most common portals of entry for the micro-organisms were gastrointestinal (42.9%), unknown (35.7%) and skin (16.7%). The most common underlying disorders were advanced malignancy (31.0%), diabetes mellitus (14.3%), none determined (12.0%) and acute cholecystitis (9.5%). The mortality rate was 23.8%. Timely appropriate treatment was started in only about half of the instances. Appropriate (recommended) treatment did not significantly affect survival (p = 0.469). Clostridial infections and bacteremia exist in the community hospital most commonly in severely ill patients. The fact that clostridia are commonly cultured in blood cultures positive for other bacterial pathogens and that appropriate treatment for clostridia did not affect patient survival, call into question the significance and pathogenicity of clostridial organisms. On the other hand, if clostridial bacteremia was not considered in half these patients with bacteremia, it is possible that more indolent clostridial infections are being overlooked.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10716073     DOI: 10.1080/00365540050164173

Source DB:  PubMed          Journal:  Scand J Infect Dis        ISSN: 0036-5548


  7 in total

1.  Clostridium bacteraemia characterised by 16S ribosomal RNA gene sequencing.

Authors:  P C Y Woo; S K P Lau; K-M Chan; A M Y Fung; B S F Tang; K-Y Yuen
Journal:  J Clin Pathol       Date:  2005-03       Impact factor: 3.411

2.  Non-toxigenic Clostridium sordellii: clinical and microbiological features of a case of cholangitis-associated bacteremia.

Authors:  Seth T Walk; Ruchika Jain; Itishree Trivedi; Sylvia Grossman; Duane W Newton; Tennille Thelen; Yibai Hao; J Glenn Songer; Glen P Carter; Dena Lyras; Vincent B Young; David M Aronoff
Journal:  Anaerobe       Date:  2011-06-25       Impact factor: 3.331

3.  Massive intravascular hemolysis is an important factor in Clostridium perfringens-induced bacteremia.

Authors:  Ai Suzaki; Shihoko Komine-Aizawa; Hiroyuki Nishiyama; Satoshi Hayakawa
Journal:  Intern Emerg Med       Date:  2022-08-13       Impact factor: 5.472

4.  Risk factors for mortality in patients with anaerobic bacteremia.

Authors:  J R Wilson; A P Limaye
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2004-03-13       Impact factor: 3.267

5.  Empyema caused by Clostridium bifermentans: A case report.

Authors:  Safa Edagiz; Phil Lagace-Wiens; John Embil; James Karlowsky; Andrew Walkty
Journal:  Can J Infect Dis Med Microbiol       Date:  2015 Mar-Apr       Impact factor: 2.471

6.  Epidemiology, aetiology and clinical characteristics of clostridial bacteraemia: a 6-year population-based observational study of 386 patients.

Authors:  Maaria Sarasoja; Bo Nilson; Daniel Wide; Åsa Lindberg; Gustav Torisson; Karin Holm
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2022-09-22       Impact factor: 5.103

Review 7.  An alternate pathophysiologic paradigm of sepsis and septic shock: implications for optimizing antimicrobial therapy.

Authors:  Anand Kumar
Journal:  Virulence       Date:  2013-11-01       Impact factor: 5.882

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.